title: Cost-benefit of the 21-gene breast cancer recurrence score assay for patients in Singapore.
authors: Gilberto
authors: G
authors: de Lima Lopes
authors: Rebecca
authors: R
authors: Chien
authors: John
authors: J
authors: Hornberger
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000191:economics* / Q000235:genetics*; D017024:Chemotherapy, Adjuvant / Q000191:economics; D003362:Cost-Benefit Analysis; D005260:Female; D017048:Health Care Costs; D006801:Humans; D009364:Neoplasm Recurrence, Local; D011960:Receptors, Estrogen / Q000235:genetics; D018570:Risk Assessment / Q000191:economics; D012846:Singapore
chemical_list: D011960:Receptors, Estrogen